Statistics for Harvard Bioscience (id:6718 HBIO)

Valuation metrics

Market cap

93.34M

Enterprise value

134.68M

Trailing P/E (ttm)

-27.00

Forward P/E

14.27

PEG ratio

14.27

Price/Sales (ttm)

0.96

Price/Book (mrq)

1.43

Enterprise Value/Revenue

1.38

Enterprise Value/EBITDA

46.73

Overview

Shares outstanding

43.62M

Float

35.48M

Shares short

398.84K

% Held by insiders

0.08%

% Held by institutions

0.74%

Average volume (10 days)

197.67K

Average volume (90 days)

Price summary

52-Week low

1.99

52-Week high

5.56

52-Week change

-115.74%

Beta

1.31

50-Day moving average

2.52

200-Day moving average

3.31

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

November 04th, 2013

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-14.57%

Operating margin

-7.72%

Operational effectiveness

Return on assets

-1.98%

Return on equity

-20.40%

Income statement

Revenue (ttm)

2.26

Revenue per share (ttm)

2.26

Quarterly revenue growth (yoy)

Gross profit (ttm)

66.07M

EBITDA

8.66M

Net income to common (ttm)

-14,241,000.00

Diluted EPS (ttm)

-0.33

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

4.57M

Total cash per share (mrq)

0.10

Total debt (mrq)

45.91M

Total Debt/Equity (mrq)

70.29

Current ratio (mrq)

205.70%

Book value per share (mrq)

1.50

Cash flow

Cash flow statement

4.02M

Levered free cash flow (LFCF)

6.06M